Prostate Carcinoma: Hereditary and Predictive Aspects of Molecular Pathology

Prostate carcinoma is the most common urological tumour disease with a relatively high lifetime risk for men. Molecular analyses provide important information both with regard to a hereditary predisposition of patients and with regard to predictive aspects for targeted therapy.